← 홈

전체 프로그램

ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
ADCBiologicAbbVievedotin and mirvetuximab so…Phase 2

Lubricating Eye Drops (Lubricating Eye Drops)

Recurrent Ovarian Cancer; Folate Receptor-Alpha Positive · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 0.02%임상시험 60상태 RECRUITING
CGTBiologicstaleMedigene AGPhase 2

Lymphodepletion (Lymphodepletion)

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · FRα

#FR#CGT#Phase2#인기#세포유전치료+5
효능 0%임상시험 60상태 DISCONTINUED
CGTBiologicstaleTurnstone Biologics, Corp.Phase 1

RT-01 (Oncolytic Virus Injection, Oncolytic Virus Injection(RT-01))

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#인기#세포유전치료+4
효능 ORR 28%임상시험 60상태 ACTIVE
ADCBiologicstaleOnconic Therapeutics Inc.releasePhase 2

PARP inhibitor (PARP inhibitor)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 27.66%임상시험 60상태 RECRUITING
ADCBiologicBioNTech SEPhase 2

Paroxetine (Paroxetine)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#인기#항체약물접합체+2
임상시험 60상태 RECRUITING
CGTBiologicAbbottPhase 2

Pegylated asparaginase (Pegylated asparaginase)

B Lymphoblastic Leukemia · B Lymphoblastic Leukemia

#BLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+4
효능 ORR 14.3%임상시험 60상태 RECRUITING
ADCBiologicCastilla-La Mancha Health Servi…vedotin (RC48) combined wit…Phase 2

Perioperative treatment (Perioperative treatment)

Hepatoid Adenocarcinoma of Stomach · Hepatoid Adenocarcinoma of Stomach

#HepatoidAdenocarcinomaofStomach#ADC#Phase2#인기#항체약물접합체+3
임상시험 60상태 RECRUITING
AntibodyRocheDeruxtecan plus Pertuzumab …Phase 2

trastuzumab (Herceptin, Pertuzumab + trastuzumab)

Elderly Metastatic Breast Cancer Population · Elderly Metastatic Breast Cancer Populat

#ElderlyMetastaticBreastCancerPop#Antibody#Phase2#인기#항체+5
효능 ORR 88.6%임상시험 60상태 ACTIVE
ADCBiologicCzech Lymphoma Study GroupPhase 2

Prednisone tablet (Prednisone tablet)

Lymphoma, T-Cell, Peripheral · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 85.5%임상시험 60상태 ACTIVE
ADCBiologicstaleQilu Pharmaceutical Co., Ltd.Phase 2

QL1706 (QL1706)

TNBC, Triple Negative Breast Cancer · Recurrent Cervical Cancer

#RecurrentCervicalCancer#ADC#Phase2#인기#항체약물접합체+5
임상시험 60상태 RECRUITING
AntibodystaleSun Yat-sen Universityvedotin combined with immun…Phase 3

Serplulimab (Serplulimab)

Colorectal Cancer; Liver Metastases · Solid Tumor Cancer

#SolidTumorCancer#Antibody#Phase3#인기#항체+5
임상시험 60상태 RECRUITING
CGTBiologicstaleLion TCR Pte. Ltd.Phase 1

TCR-T (TCR-T)

Chronic Hepatitis B · Chronic Hepatitis B

#ChronicHepatitisB#CGT#Phase1#인기#세포유전치료+4
효능 ORR 50%임상시험 60상태 ACTIVE
CGTBiologicMedigene AGPhase 1

MDG1015 (TCR-T cells, TCR-T cells (MDG1015))

Epithelial Ovarian Cancer; Gastro-esophageal Junction Cancer · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#CGT#Phase1#인기#세포유전치료+5
효능 ORR 11.8%임상시험 60상태 RECRUITING
ADCBiologicAscendis Pharma Endocrinology D…Preclinical

Targeted drugs (Targeted drugs)

Immune-related Adverse Event; Malignant Solid Tumors · Immune-related Adverse Event

#Immune-relatedAdverseEvent#ADC#Preclinical#인기#항체약물접합체+4
효능 ORR 15%임상시험 60상태 RECRUITING
AntibodystaleJanssenApproved

Teclistamab (Teclistamab)

Myeloma Multiple; Plasma Cell Leukemia · Myeloma Multiple

#MyelomaMultiple#Antibody#Approved#인기#항체+5
임상시험 60상태 RECRUITING
ADCBiologicMylan Pharmaceuticals IncDM1A-mediated epigenetic si…Phase 1

Verapamil (Verapamil)

Recurrent Hodgkin Lymphoma; Refractory Hodgkin Lymphoma · FRα

#FR#ADC#Phase1#인기#항체약물접합체+5
임상시험 60상태 ACTIVE
CGTBiologicstaleAbbottvedotinPhase 2

Zidovudine (Zidovudine)

Lymphoproliferative Disorder; HHV-8 · Adult T-cell Leukemia-Lymphoma

#AdultT-cellLeukemia-Lymphoma#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 RECRUITING
CGTBiologicstaleSabz BiomedicalsPhase 2

cytokine-induced killer cell (cytokine-induced killer cell)

Colon Cancer Stage IV · Solid Tumors

#SolidTumors#CGT#Phase2#인기#세포유전치료+5
임상시험 60상태 ACTIVE
ADCBiologicstaleCanadian Cancer Trials Groupderuxtecan (T-DXd) showed a…Phase 2

darolutamide (darolutamide)

Prostate Cancer · Genitourinary Cancers

#GenitourinaryCancers#ADC#Phase2#인기#항체약물접합체+4
임상시험 60상태 RECRUITING
ADCBiologicMerckVedotin ± Pe…Phase 2

nivolumab OR pembrolizumab (glembatumumab vedotin and PD-1 targeted checkpoint inhibitor, glembatumumab vedotin and PD-1 targeted checkpoint inhibitor (nivolumab OR pembrolizumab))

Melanoma · PD-1

#PD-1#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 50%임상시험 60상태 DISCONTINUED

15 / 177 페이지

← 이전다음 →